KBI Biopharma is a global contract development and manufacturing organization (CDMO) that provides fully integrated drug development and biomanufacturing services to life science companies. The firm operates from Durham, North Carolina, USA, and serves clients globally, combining scientific expertise with operational execution. It is part of the JSR Life Sciences group and has been in operation for nearly three decades.
The company's service portfolio spans the full development pipeline, covering areas such as mammalian cell line development, microbial expression systems, process development, analytical development, formulation, characterization, and both clinical and commercial manufacturing. Its proprietary technology platforms include the SUREtechnology Platform for mammalian systems and the PUREplatform for microbial expression systems.
KBI Biopharma's standing in the CDMO sector has been recognized with top honors in industry leadership awards in 2025. The organization works across biopharmaceutical development and biologics, supporting clients from early-stage development through to commercial-scale production.
